Health Care/Hospital

BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers

MUNICH, March 25, 2021 /PRNewswire/ -- IQM Quantum Computers  (IQM) announced today that Helmut Jeggle has joined IQM´s board of directors. He joins the company during a transformational phase. After successfully closing its Series A funding round and selling its first q...

2021-03-25 18:29 2577

AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine

AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou,...

2021-03-25 17:00 2396

GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development

SINGAPORE, March 25, 2021 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announced that the Company has entered into a strategic partnership with the Theragen Etex, a South Korea-based comprehensive pharmaceutical and biotechnology...

2021-03-25 16:35 3417

Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility near Narita Airport

TOKYO, March 25, 2021 /PRNewswire/ -- Nippon Express Co., Ltd. has obtained IATA CEIV Pharma (*) pharmaceutical transport quality certification for its Narita Temperature-Controlled Hub (NTCH) and for transport operations between NTCH and Narita Airport, effectiveMarch 15. This is the second pha...

2021-03-25 15:00 2072

No COVID slump as majority of Australians satisfied with healthcare system new Australian Healthcare Index reports

MELBOURNE and PERTH, Australia, March 25, 2021 /PRNewswire/ -- Despite a once-in-a-century pandemic still lingering one year on, Australians have given a vote of confidence to the Australian healthcare system with 65.5% rating it a score of 8 or above out of 10 in a new report, produced by the Au...

2021-03-25 03:00 1602

Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar

TAIPEI, March 24, 2021 /PRNewswire/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary endpoint. E...

2021-03-24 23:27 2868

Ping An and Zhongshan Hospital to Collaborate on "Healthcare + Finance + Technology" Innovations

HONG KONG and SHANGHAI, March 24, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) has signed a strategic cooperation agreement with Zhongshan Hospital, which is affiliated with Fudan University inShanghai. The two ...

2021-03-24 20:15 5563

Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant  expertise in US, EU, and Asia-Pacific markets LONDON, March 24, 2021 /PRNewswire/ -- Leading life science commercialization partnerFishawack H...

2021-03-24 20:00 1758

Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation

SUZHOU, China and ROCKVILLE, Md., March 24, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Ev...

2021-03-24 19:07 1641

LimaCorporate And HSS Partner To Open First Provider-based Design And 3D Printing Center For Complex Joint Reconstruction Surgery

SAN DANIELE DEL FRIULI, Italy, March 24, 2021 /PRNewswire/ -- LimaCorporate  S.p.A., (Lima) leading global orthopedics manufacturer, andHospital for Special Surgery (HSS), top-ranked in orthopedics for 11 consecutive years in the U.S., byU.S. New...

2021-03-24 16:00 1857

Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate

* Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA acrossLatin America, Asia, Europe and Africa * Interim analysis of the primary endpoint expected in the middle of 2021 CHENGDU, China and EMERYVILLE, Calif., March 24, 2021 /PRNewswire/ -- Clover Biopharm...

2021-03-24 14:18 2911

Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA

HONG KONG, March 23, 2021 /PRNewswire/ -- Forest Hills Partners Hong Kong Limited (also known as Forest Hills Lab) is ready to file an Investigative New Drug (IND) application with the US FDA inApril 2021 to assess tolerability and efficacy with one of its drug candidates, namely FHL-301 in a pha...

2021-03-24 12:25 5123

Mindray Releases New Ceiling Supply Unit, Creating a More Optimized ICU Environment

SHENZHEN, China, March 24, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in developing and providing medical devices, has released a new series of ceiling supply units which exceeds ISO 11197-2019 standards. The HyPort R80 is the newest generation of bedside device management syste...

2021-03-24 11:49 1722

CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients

* GAVRETO has been approved for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer after platinum-based chemotherapy * GAVRETO is the first approved selective RET inhibitor in China and first approved precision therapy for CStone SUZHOU,...

2021-03-24 10:46 4795

Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial

Data presented at ENDO 2021 demonstrate clinically relevant weight loss, without weight regain, in people treated with semaglutide 2.4 mg vs placebo in combination with lifestyle intervention. BAGSVÆRD, Denmark, March 24, 2021 /PRNewswire/ -- New results from the STEP phase 3a clinical trial p...

2021-03-24 04:41 1331

RDIF: Sputnik V approved in Vietnam

MOSCOW, March 23, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of the Socialist Republic ofVietnam. Thus Sputnik V is now approved for use in 56...

2021-03-23 20:45 2265

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

RARITAN, N.J., March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics  (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received authorization from the U.S. Food and Drug Administration to update key claims for the VITROS® SARS-CoV-2 Antige...

2021-03-23 20:00 2854

Pharmactive Earns Acclaim from Frost & Sullivan for Helping People Improve their Cognitive Functions with its Saffron-based Ingredient, Affron®

The company's proven ability to reduce symptoms of occasional depression with Affron®, and its strong focus on quality control, have helped it deliver a truly outstanding product LONDON, March 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American market for industrial enter...

2021-03-23 20:00 1190

Pharma Industry to Spend $4.5 Billion on Digital Transformation by 2030

While the creation, manufacture, and supply of COVID vaccines are grabbing attention, behind the scenes, pharma manufacturers are digitizing at pace LONDON, March 23, 2021 /PRNewswire/ -- Pharma 4.0 concepts are taking hold in pharmaceutical manufacturing. The industry's unique characteristics ar...

2021-03-23 16:00 1297

Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

PARIS, March 23, 2021 /PRNewswire/ -- Unither Pharmaceuticals, the Blow-Fill-Seal (BFS) worldwide leader, provides diagnostic companies with capacity solutions and innovative technologies for their testing kits (Covid, Flu, etc.).

2021-03-23 15:04 2038
1 ... 356357358359360361362 ... 554